BNN Bloomberg’s Market Call featured Velocity Investment Counsel’s Brianne Gardner on Oct. 31, who highlighted TMX Group (TMX Group Stock Quote, Chart, News, Analysts, Financials TSX:X) as a name she continues to favour, emphasizing the company’s growing data-driven revenue mix and earnings resiliency.
Gardner noted that while TMX is best known for operating the Toronto Stock Exchange and related trading platforms, “it’s not just trading — data and analytics now make up 42% of their total revenue and [are] growing double digits.”
She said this segment helps smooth out cyclical swings in capital markets activity, particularly when new listings slow.
The fund manager pointed to accelerating momentum in derivatives, which delivered 27% year-over-year growth, and highlighted TMX’s healthy balance sheet and reliable dividend. The recent pullback, she added, “wouldn’t be a bad time to be adding,” calling the weakness largely a function of fewer IPOs.
“The strength in the data and the derivatives can keep the earnings picture more stable,” she said, adding the stock ranks nine out of 10 for her team, with “just over 25% upside from here.”
TMX shares have gained 15.13% over the past 12 months and 95.23% over five years. Of the analysts covering the stock, six rate it “Buy,” two “Hold,” and none “Sell,” with a consensus price target of $62.50.
The shares closed Nov. 3 at $51.73.
-30-
Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and $130.00 target on Graham Corporation (Graham Corporation Stock Quote, Chart,… [Read More]
Beacon Securities analyst Doug Cooper says iFabric’s (iFabric Stock Quote, Chart, News, Analysts, Financials TSX:IFA) medical scrubs opportunity is being… [Read More]
Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and street-high $88.00 target on MDA Space (MDA Space Stock Quote,… [Read More]
National Bank Financial analyst Baltej Sidhu raised his target on Hammond Power Solutions (Hammond Power Solutions Stock Quote, Chart, News,… [Read More]
RBC senior economist Claire Fan says Canada’s September job losses were concentrated among younger workers and should not be overread.… [Read More]
Roth Capital Partners analyst Adam Walsh says a third controlled celiac disease dataset supporting IL-15 blockade increases the potential value… [Read More]